| Bristol-Myers Squibb SA - REVLIMID 15 mg, Hartkapseln | | 57712 | | 03 | | REVLIMID 15 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 29.08.2007 | | |
| | Composition | | lenalidomidum 15 mg, lactosum 289 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.8 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Lenalidomidum | 15 mg |
| | BAG: Active Agent | Dose |
|---|
| Lenalidomidum | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | 289 mg | | | | | | | | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 21 Capsule(s) | 2609.31 | 2741.75 | A | SL | No |
|
|
